Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

Published:2011-09-08 Issue:2 Volume:57 Page:545-553
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Malaguarnera Michele,Vacante Marco,Antic Tijana,Giordano Maria,Chisari Giuseppe,Acquaviva Rosaria,Mastrojeni Silvana,Malaguarnera Giulia,Mistretta Antonio,Li Volti Giovanni,Galvano Fabio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-011-1887-4.pdf

Reference47 articles.

1. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet. 1999;353:1634–1636.

2. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35:367–372.

3. Hodge A, Hodge S, Chitturi S. Adipocytokine polymorphisms and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24:173–175.

4. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513–1517.

5. Musso G, Gambino R, Cassader M, Pagano G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology. 2010;52:79–104.

Cited by 376 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials;Pharmacological Research;2024-10

2. Food-derived exosomes as the future of drug delivery;Nano Research;2024-09-05

3. Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges;Engineering;2024-09

4. The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated Review;Current Research in Nutrition and Food Science Journal;2024-08-30

5. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials;BMC Gastroenterology;2024-08-22